Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Sep 10;15(9):e44995.
doi: 10.7759/cureus.44995. eCollection 2023 Sep.

Anaplastic Large Cell Lymphoma Misdiagnosed as Systemic Lupus Erythematosus: A Report of a Rare Case

Affiliations
Case Reports

Anaplastic Large Cell Lymphoma Misdiagnosed as Systemic Lupus Erythematosus: A Report of a Rare Case

Khadeejeh M Alfroukh et al. Cureus. .

Abstract

Non-Hodgkin lymphomas are a diverse group of lymphoproliferative disorders rising from the lymphocytes with a broad spectrum of histological characteristics and clinical manifestations that often complicate accurate diagnosis. Autoantibodies have been observed at higher frequencies in lymphoproliferative diseases, yet the precise role of the immune system and the underlying causative factors remain enigmatic. Anaplastic large cell lymphoma (ALCL), an aggressive non-Hodgkin's lymphoma variant, commonly presents in a manner akin to other aggressive lymphomas, featuring swift progression of peripheral and/or retroperitoneal adenopathy, accompanied by systemic symptoms like fever, night sweats, and weight loss. This case report delves into a histologically verified instance of ALCL, which strikingly emulates systemic lupus erythematosus. This report's objective is to underscore the concept that lymphoma can manifest clinical or biological features reminiscent of autoimmunity.

Keywords: autoimmune disorders; lymphadenopathy; misdiagnosis; multidisciplinary collaboration; non-hodgkin lymphoma; systemic lupus erythematosus.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Multiple brown-to-black patches and hypopigmented macules on hands.
Figure 2
Figure 2. Correlated Inguinal ultrasound shows multiple prominent bilateral oval-shaped inguinal lymph nodes with preserved fatty hilum.
Figure 3
Figure 3. Selected image of axial contrast-enhanced abdominal CT scan showing multiple enlarged pelvic lymph nodes, the largest measures about 24 x 14 mm noted at the left external iliac group.
Figure 4
Figure 4. Selected cut of enhanced axial abdominal CT scan showing multiple enlarged para-aortic lymph nodes, the largest measures about 19 x 12 mm noted at the left para-aortic group at the level of the left kidney hilum.
Figure 5
Figure 5. Selected image of axial contrast-enhanced abdominal CT scan showing multiple prominent bilateral inguinal lymph nodes.
Figure 6
Figure 6. (A) Monomorphic to pleomorphic large lymphocytes with prominent nucleoli and abundant eosinophilic cytoplasm (H&E: 20x); (B)Tumor infiltration of lymph node sinuses. Some of the large cells have horseshoe or doughnut-shaped nuclei (hallmark cells) (H&E: 40x); (C) Diffusely positive CD30 immunostaining.
H&E: hematoxylin and eosin; CD: cluster of differentiation

References

    1. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Aringer M, Costenbader K, Daikh D, et al. Arthritis Rheumatol. 2019;71:1400–1412. - PMC - PubMed
    1. Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity. Bernatsky S, Boivin JF, Joseph L, St Pierre Y, Moore A, Rajan R, Clarke A. https://www.jrheum.org/content/29/12/2551.long. J Rheumatol. 2002;29:2551–2554. - PubMed
    1. Hematological malignancies in systemic lupus erythematosus: clinical characteristics, risk factors, and prognosis-a case-control study. Zhang Y, Li W, Zhang P, Guo J, Sun J, Lu J, Liu S. Arthritis Res Ther. 2022;24:5. - PMC - PubMed
    1. Clinical significance of elevated antinuclear antibodies in patients with diffuse large B-cell lymphoma: a single center study. Lang J, Ma K, Guo J, Zhang J, Wang Q, Sun H. J Cancer Res Ther. 2018;14:213–219. - PubMed
    1. SLE and non-Hodgkin's lymphoma: a case series and review of the literature. Boddu P, Mohammed AS, Annem C, Sequeira W. Case Rep Rheumatol. 2017;2017:1658473. - PMC - PubMed

Publication types

LinkOut - more resources